For sustained results, many healthcare providers recommend regular treatments, typically ranging from weekly to monthly sessions depending on your specific goals and health status
1 Clinical Trials and Efficacy Rigorous clinical trials particularly the Semaglutide Treatment Effect in People with Obesity (STEP) 2 trial (ClinicalTrials.gov identifier: NCT03552757), SURPASS-1 (ClinicalTrials.gov identifier: NCT03954834), and SURPASS-2 (ClinicalTrials.gov identifier: NCT03987919) assessed its efficacy in overweight or obese patients, with or without type 2 diabetes
What should I avoid ordering at restaurants on GLP-1s
Men who maintain protocols for twelve months and beyond often achieve results exceeding clinical trial averages
[ SOURCE: Reuters] As of June 2, 2025, the JPML reports there are 1,882 cases pending in the MDL -3094 IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation